I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| non-classical monocyte | 7 studies | 35% ± 23% | |
| endothelial cell | 7 studies | 25% ± 8% | |
| smooth muscle cell | 6 studies | 21% ± 4% | |
| natural killer cell | 5 studies | 21% ± 7% | |
| CD8-positive, alpha-beta T cell | 4 studies | 25% ± 8% | |
| conventional dendritic cell | 4 studies | 32% ± 23% | |
| fibroblast | 4 studies | 21% ± 3% | |
| pericyte | 4 studies | 22% ± 5% | |
| T cell | 3 studies | 22% ± 4% | |
| B cell | 3 studies | 18% ± 0% | |
| CD4-positive, alpha-beta T cell | 3 studies | 26% ± 6% | |
| mature NK T cell | 3 studies | 22% ± 6% | |
| abnormal cell | 3 studies | 19% ± 3% | |
| plasma cell | 3 studies | 30% ± 14% | |
| epithelial cell | 3 studies | 31% ± 7% | |
| ciliated cell | 3 studies | 21% ± 4% | |
| regulatory T cell | 3 studies | 20% ± 3% |
